Roche remains optimistic the field of Alzheimer’s research is moving toward medicines that will make a difference, even though its own drug failed in a highly anticipated trial https://t.co/SEwIu8pKw7— Bloomberg (@business) November 14, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


